143 related articles for article (PubMed ID: 37114736)
1. Apical papillary muscle displacement is a prevalent feature and a phenotypic precursor of apical hypertrophic cardiomyopathy.
Filomena D; Vandenberk B; Dresselaers T; Willems R; Van Cleemput J; Olivotto I; Robyns T; Bogaert J
Eur Heart J Cardiovasc Imaging; 2023 Jul; 24(8):1009-1016. PubMed ID: 37114736
[TBL] [Abstract][Full Text] [Related]
2. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Kwon DH; Setser RM; Thamilarasan M; Popovic ZV; Smedira NG; Schoenhagen P; Garcia MJ; Lever HM; Desai MY
Heart; 2008 Oct; 94(10):1295-301. PubMed ID: 17690158
[TBL] [Abstract][Full Text] [Related]
3. Structural abnormalities in hypertrophic cardiomyopathy beyond left ventricular hypertrophy by multimodality imaging evaluation.
Urbano-Moral JA; Gutierrez-Garcia-Moreno L; Rodriguez-Palomares JF; Matabuena-Gomez-Limon J; Niella N; Maldonado G; Valle-Racero JI; Niella M; Teixido-Tura G; Garcia-Dorado D; Ferrazzi P; Pandian NG; Evangelista-Masip A
Echocardiography; 2019 Jul; 36(7):1241-1252. PubMed ID: 31162742
[TBL] [Abstract][Full Text] [Related]
4. Solitary papillary muscle hypertrophy as a possible form of hypertrophic cardiomyopathy.
Kobashi A; Suwa M; Ito T; Otake Y; Hirota Y; Kawamura K
Jpn Circ J; 1998 Nov; 62(11):811-6. PubMed ID: 9856596
[TBL] [Abstract][Full Text] [Related]
5. Assessment of mitral valve function in children and young adults with hypertrophic cardiomyopathy using three-dimensional echocardiography.
Joseph N; Craft M; Mill L; Erickson CC; Danford DA; Kutty S; Li L
Int J Cardiol; 2021 Jun; 332():182-188. PubMed ID: 33753187
[TBL] [Abstract][Full Text] [Related]
6. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
[TBL] [Abstract][Full Text] [Related]
7. Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
Khoury S; Bhatia RT; Marwaha S; Miles C; Kasiakogias A; Bunce N; Behr E; Papadakis M; Sharma S; Tome M
Int J Cardiol; 2023 Nov; 391():131265. PubMed ID: 37574022
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy.
Flett AS; Maestrini V; Milliken D; Fontana M; Treibel TA; Harb R; Sado DM; Quarta G; Herrey A; Sneddon J; Elliott P; McKenna W; Moon JC
Int J Cardiol; 2015 Mar; 183():143-8. PubMed ID: 25666123
[TBL] [Abstract][Full Text] [Related]
9. Patients who do not fulfill criteria for hypertrophic cardiomyopathy but have unexplained giant T-wave inversion: a cardiovascular magnetic resonance mid-term follow-up study.
Li S; He J; Xu J; Zhuang B; Wu B; Wei B; Huang J; Yin G; Chen X; Zhu Z; Wang H; Zhao S; Lu M
J Cardiovasc Magn Reson; 2021 Jun; 23(1):67. PubMed ID: 34078401
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
[TBL] [Abstract][Full Text] [Related]
11. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
Maron MS
J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
[TBL] [Abstract][Full Text] [Related]
12. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Gruner C; Chan RH; Crean A; Rakowski H; Rowin EJ; Care M; Deva D; Williams L; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Siminovitch K; Ralph-Edwards AC; Rastegar H; Maron BJ; Maron MS
Eur Heart J; 2014 Oct; 35(39):2706-13. PubMed ID: 24810389
[TBL] [Abstract][Full Text] [Related]
13. Isolated papillary muscle hypertrophy: A gap in our knowledge of hypertrophic cardiomyopathy?
Ferreira C; Delgado C; Vázquez M; Trinidad C; Vilar M
Rev Port Cardiol; 2014 Jun; 33(6):379.e1-5. PubMed ID: 25001167
[TBL] [Abstract][Full Text] [Related]
14. Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance.
Yang K; Yu SQ; Chen XY; Song YY; Yang SJ; Cui C; Zhao KK; Wei MD; Lu MJ; Zhao SH
Int J Cardiol; 2023 Jan; 371():480-485. PubMed ID: 36115439
[TBL] [Abstract][Full Text] [Related]
15. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
Harrigan CJ; Appelbaum E; Maron BJ; Buros JL; Gibson CM; Lesser JR; Udelson JE; Manning WJ; Maron MS
Am J Cardiol; 2008 Mar; 101(5):668-73. PubMed ID: 18308018
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional echocardiographic observation of the short axis views of the left ventricle in hypertrophic cardiomyopathy.
Isshiki T; Umeda T; Machii K
Jpn Heart J; 1980 May; 21(3):297-305. PubMed ID: 7190625
[TBL] [Abstract][Full Text] [Related]
17. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
[TBL] [Abstract][Full Text] [Related]
18. Morphological quantification and differentiation of left ventricular hypertrophy in hypertrophic cardiomyopathy and hypertensive heart disease. A two dimensional echocardiographic study.
Keller H; Wanger KC; Goepfrich M; Stegaru B; Buss J; Heene DL
Eur Heart J; 1990 Jan; 11(1):65-74. PubMed ID: 2137778
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional echocardiography for the assessment of left ventricular geometry and papillary muscle morphology in hypertrophic cardiomyopathy.
Erden M; van Velzen HG; Menting ME; van den Bosch AE; Ren B; Michels M; Vletter WB; van Domburg RT; Schinkel AFL
J Ultrasound; 2018 Mar; 21(1):17-24. PubMed ID: 29374400
[TBL] [Abstract][Full Text] [Related]
20. Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers.
Lyon A; Ariga R; Mincholé A; Mahmod M; Ormondroyd E; Laguna P; de Freitas N; Neubauer S; Watkins H; Rodriguez B
Front Physiol; 2018; 9():213. PubMed ID: 29593570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
